• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Novo Nordisk AS(NVO.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Jan2
Trump Administration Strikes Deal with Nine Major Pharmaceutical Companies to Cut Prices
00:00
Jan1
Novo Nordisk has announced its dividend plan for August 2026.
22:51
Novo Nordisk stock ex-dividend date
14:02
Analyst Comments on Market Outlook for Novo Nordisk's Oral Weight Loss Pill
06:10
Phase 3 Clinical Trial to Evaluate Semaglutide for Alcohol Use Disorder Is Estimated to Start
00:00
Dec31
Novo Nordisk's high-dose injectable Wegovy poised for US and EU approval in early 2026
23:40

Schedules & Filings

Schedules
Filings
Feb4
Earning Release(EST)

FY2025 Annual Earning Release

Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.78 B, Net Income 3.143 B, EPS 0.707

Novo Nordisk A/S (NVO.US) Q3 2025 Earnings Conference CallNovo Nordisk A/S (NVO.US) Q3 2025 Earnings Conference Call
Aug26
Distribution Plan(EST)

Cash dividend 0.5843 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More